Cargando…

The Value of a Patient-Level Modeling Approach and Need for Better Reporting in Economic Evaluations of Osteoporosis

Detalles Bibliográficos
Autores principales:	Hiligsmann, Mickael, Reginster, Jean-Yves, Silverman, Stuart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2020
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390972/ https://www.ncbi.nlm.nih.gov/pubmed/32105170 http://dx.doi.org/10.18553/jmcp.2020.26.3.334

Ejemplares similares

Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
por: Li, Nannan, et al.
Publicado: (2023)

Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
por: Li, Nannan, et al.
Publicado: (2023)

Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
por: Beaudart, Charlotte, et al.
Publicado: (2021)

FRI682 Cost Effectiveness Of Four Treatment Approaches For US Women And Men At Very High Risk Of Osteoporotic Fractures
por: Hiligsmann, Mickael, et al.
Publicado: (2023)

An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
por: Li, Nannan, et al.
Publicado: (2020)

Patients’ preferences for osteoporosis drug treatment: a discrete-choice experiment
por: Hiligsmann, Mickaël, et al.
Publicado: (2014)

Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States
por: Hiligsmann, Mickaël, et al.
Publicado: (2023)

Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures
por: Ethgen, Olivier, et al.
Publicado: (2015)

Health Technology Assessment in Osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2013)

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
por: Hiligsmann, M., et al.
Publicado: (2019)

Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2013)

A Qualitative Study to Assess US Patient Preferences between new Transdermal System and Injectable Anabolic Therapies for Osteoporosis Treatment
por: Beaudart, Charlotte, et al.
Publicado: (2022)

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
por: Hiligsmann, M., et al.
Publicado: (2018)

A scoping review of the public health impact of vitamin D-fortified dairy products for fracture prevention
por: Hiligsmann, Mickael, et al.
Publicado: (2017)

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis
por: Hiligsmann, M., et al.
Publicado: (2013)

Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments
por: Dangouloff, Tamara, et al.
Publicado: (2021)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Moon, Rebecca J., et al.
Publicado: (2023)

Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
por: Chandran, M., et al.
Publicado: (2020)

A Review of Patient Preferences for Osteoporosis Drug Treatment
por: Hiligsmann, Mickaël, et al.
Publicado: (2015)

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy
por: Hiligsmann, M., et al.
Publicado: (2021)

Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France
por: Hiligsmann, M., et al.
Publicado: (2016)

Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review
por: Cornelissen, D., et al.
Publicado: (2020)

Osteoporosis and sarcopenia: two diseases or one?
por: Reginster, Jean-Yves, et al.
Publicado: (2016)

Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide
por: Reginster, Jean-Yves, et al.
Publicado: (2018)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11): A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ESCEO) and the International Osteoporosis and Other Skeletal Diseases Foundation (IOF)
por: Rabenda, Véronique, et al.
Publicado: (2015)

An introduction to health technology assessment and health economic evaluation: an online self-learning course
por: Wiethoff, Isabell, et al.
Publicado: (2023)

Does the Structure Matter? An External Validation and Health Economic Results Comparison of Event Simulation Approaches in Severe Obesity
por: Schwander, Björn, et al.
Publicado: (2022)

Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review
por: Beaudart, Charlotte, et al.
Publicado: (2021)

Designing economic evaluations to facilitate optimal decisions: the need to avoid bias
por: Lee, Karen M, et al.
Publicado: (2016)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Bruyère, Olivier, et al.
Publicado: (2017)

Replication of Published Health Economic Obesity Models: Assessment of Facilitators, Hurdles and Reproduction Success
por: Schwander, Björn, et al.
Publicado: (2021)

Early intervention for subthreshold panic disorder in the Netherlands: A model-based economic evaluation from a societal perspective
por: Ophuis, Robbin H., et al.
Publicado: (2018)

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report
por: Rizzoli, R., et al.
Publicado: (2010)

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
por: Hiligsmann, M., et al.
Publicado: (2019)

Transparency Needed for Economic Analyses of PA Programs
por: Holdford, David
Publicado: (2003)

Machine learning and health need better values
por: Ghassemi, Marzyeh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ehmmjjb6vmupujjle38hl0f44b